Skip to Content
You are currently on the new version of our website. Access the old version .
  • Review
  • Open Access

17 February 2025

32 Pages

Antifungal Natural Products Originating from Endophytic and Rhizospheric Microbes Isolated from Coastal Vegetation

,
and
1
School of Science, RMIT University, Bundoora, VIC 3083, Australia
2
ARC Training Centre for Hyphenated Analytical Separation Technologies (HyTECH), CASS Food Research Centre, School of Exercise and Nutrition Sciences, Deakin University, Burwood, VIC 3125, Australia
*
Author to whom correspondence should be addressed.

Abstract

Candida infections severely impact patients who are immunocompromised. Currently, there are limited options to treat fungal infections, especially drug-resistant-fungal infections. Therefore, investigating alternative or repurposed antifungals is paramount. Endophytic microbes (EMs) and rhizospheric microbes (RMs) emerge as promising reservoirs of bioactive natural compounds. Interestingly, plants that have adapted to various environmental conditions harbour a plethora of microbes producing a variety of bioactive natural products that can be assessed for potential antifungal activity. To date, EMs and RMs residing in coastal plants and their associated antifungals have not been extensively studied or reviewed. Therefore, this comprehensive review will focus on antifungal natural products, extracted from coastal-vegetation-associated microbiota to draw the attention of research in this field. A comprehensive literature search was conducted by examining both Scopus and Google Scholar databases during the period of 2013–2024 related to the following coastal vegetation: mangroves, sand dune plants, salt marsh plants, and seagrasses. To date, 65 novel antifungal compounds derived from coastal-plant EMs and RMs have been identified. Mangroves were found to be the most prominent host harbouring antifungal-producing EMs and RMs compared with other coastal plants. Coastal-plant-associated fungal partners were the most prominent producers of antifungals compared to their bacterial counterparts. Fifty-four fungal-EM/RM derived antifungals have been reported to demonstrate activities against plant pathogenic fungi as well as human fungal pathogens. Most of the bacterial-derived antifungals (11 antifungals) have previously been reported to have antifungal activity against Candida albicans.

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.